Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre European phase IIb study of ICES 13 for the treatment of stress urinary incontinence

Next Previous
X
Search
Trial Profile

Multicentre European phase IIb study of ICES 13 for the treatment of stress urinary incontinence

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2016

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ICES 13 (Primary)
  • Indications Stress incontinence
  • Focus Therapeutic Use
  • Sponsors Innovacell Biotechnologie GmbH

    • Most Recent Events

    • 04 Mar 2015 New source identified and integrated (European Clinical Trials database:2014-001656-34)
    • 04 Mar 2015 According to the European Clinical Trials database record, planned number of patients changed to 88.
    • 31 Dec 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top